(603566)"Pulike Biological Engineering, Inc."Announcement on Obtaining the Approval for the Clinical Trial of Veterinary Biological Products
Filed with SSE · Stock code 603566 · · 2 pages · Chinese
Summary by 6ix AI
Pulike Biological Engineering, Inc. has announced the approval for a clinical trial of a veterinary biological product, specifically an African swine fever subunit vaccine, by the Ministry of Agriculture and Rural Affairs.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Pulike Biological Engineering, Inc. on 6ix
Story so far
Earlier from Pulike Biological Engineering
- Announcement on Change of Sponsor Representative for Continuous Supervision and Guidance
- Announcement on Obtaining New Veterinary Drug Registration Certificate by Subsidiary
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
- Announcement on the Controlled Subsidiary Being Approved to Produce Foot-and-Mouth Disease Vaccine (SAT 1)
Follow Pulike Biological Engineering into a list and get an email when it puts out news.
Follow Pulike Biological Engineering